Skip to main content

Technology

Transforming vascular reconstruction

We believe the unique properties of the RFS hold tremendous potential across a range of endovascular indications to become the new standard. STENTiT is at the forefront of transforming vascular reconstruction.

See how the RFS transforms into an artery

Our pre-clinical studies show that the RFS promotes a beneficial M2-mediated macrophage response. The RFS facilitates the reconstruction of an artery including rapid endothelialization and supports the formation of a new layer of endoluminal elastin – regarded as the holy grail in tissue engineering.

STENTiT RFS stent

RFS stent creates new arterial tissue

Drag the slider to see how our stent transforms into an artery.

Features

Balloon Expandable

Transcatheter procedure

Long Lengths

Full lesion coverage

Fibrillated Scaffolding

Uniform flow & tissue integration

Natural Regeneration

Reconstructing a new artery

Controlled Resorption

Leaving nothing behind

Resorbable Fibrillated Scaffold (RFS) System

Click to learn more.

Resorbable

The RFS is designed to resorb fully within 12 months.

Strut-less design

The RFS is designed to have a smooth surface that allows for laminar blood flow through the scaffold.

Non-drug eluting

Due to the regenerative capacity of the RFS there is no need for an anti-restenotic drug to counteract progressive neointimal hyperplasia.

Catheter length

The RFS delivery system has a catheter shaft length of 150 cm.

Delivery System

The RFS is pre-mounted on a 0.014” Over-the-Wire (OTW) balloon-expandable delivery system.

Preclinical Evidence

Our pre-clinical studies show neo-endoluminal elastin formation at 6 and 8 weeks. This is considered the holy grail in tissue engineering.

Read Article